BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9037439)

  • 1. Studies on the metabolism of the new antidiabetic agent pioglitazone. Identification of metabolites in rats and dogs.
    Kiyota Y; Kondo T; Maeshiba Y; Hashimoto A; Yamashita K; Yoshimura Y; Motohashi M; Tanayama S
    Arzneimittelforschung; 1997 Jan; 47(1):22-8. PubMed ID: 9037439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition and metabolism of the hypoglycemic agent pioglitazone in rats.
    Krieter PA; Colletti AE; Doss GA; Miller RR
    Drug Metab Dispos; 1994; 22(4):625-30. PubMed ID: 7956739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys.
    Maeshiba Y; Kiyota Y; Yamashita K; Yoshimura Y; Motohashi M; Tanayama S
    Arzneimittelforschung; 1997 Jan; 47(1):29-35. PubMed ID: 9037440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone.
    Tanis SP; Parker TT; Colca JR; Fisher RM; Kletzein RF
    J Med Chem; 1996 Dec; 39(26):5053-63. PubMed ID: 8978836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on antidiabetic agents. XII. Synthesis and activity of the metabolites of (+/-)-5(-)[p(-)[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]-2,4- thiazolidinedione (pioglitazone).
    Sohda T; Ikeda H; Meguro K
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2168-72. PubMed ID: 8582019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of a new thiazolidinedione hypoglycemic agent CP-68,722 in rat: metabolite identification by gas chromatography mass spectrometry.
    Fouda HG; Lukaszewicz J; Clark DA; Hulin B
    Xenobiotica; 1991 Jul; 21(7):925-34. PubMed ID: 1776268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs.
    Kawai K; Kawasaki-Tokui Y; Odaka T; Tsuruta F; Kazui M; Iwabuchi H; Nakamura T; Kinoshita T; Ikeda T; Yoshioka T; Komai T; Nakamura K
    Arzneimittelforschung; 1997 Apr; 47(4):356-68. PubMed ID: 9150855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
    Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
    Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism in rats and man of piromidic acid, a new antibacterial agent.
    Sekine Y; Miyamoto M; Hashimoto M; Nakamura K
    Xenobiotica; 1976 Mar; 6(3):185-8. PubMed ID: 1274382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations.
    Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR
    Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformation of the novel inotropic agent toborinone (OPC-18790) in rats and dogs. Evidence for the formation of novel glutathione and two cysteine conjugates.
    Kitani M; Miyamoto G; Nagasawa M; Yamada T; Matsubara J; Uchida M; Odomi M
    Drug Metab Dispos; 1997 Jun; 25(6):663-74. PubMed ID: 9193867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel metabolites of pioglitazone in rat and dog.
    Shen Z; Reed JR; Creighton M; Liu DQ; Tang YS; Hora DF; Feeney W; Szewczyk J; Bakhtiar R; Franklin RB; Vincent SH
    Xenobiotica; 2003 May; 33(5):499-509. PubMed ID: 12746106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of glutathione conjugates derived from 4-ipomeanol metabolism in bile of rats by liquid chromatography-tandem mass spectrometry.
    Alvarez-Diez TM; Zheng J
    Drug Metab Dispos; 2004 Dec; 32(12):1345-50. PubMed ID: 15328249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation of troglitazone: identification of a reactive metabolite and mechanisms involved.
    He K; Talaat RE; Pool WF; Reily MD; Reed JE; Bridges AJ; Woolf TF
    Drug Metab Dispos; 2004 Jun; 32(6):639-46. PubMed ID: 15155556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
    Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
    Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel metabolic pathways of pioglitazone in hepatocytes: N-glucuronidation of thiazolidinedione ring and sequential ring-opening pathway.
    Uchiyama M; Fischer T; Mueller J; Oguchi M; Yamamura N; Koda H; Iwabuchi H; Izumi T
    Drug Metab Dispos; 2010 Jun; 38(6):946-56. PubMed ID: 20185540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of carbon-14-labeled muraglitazar in male mice: interspecies difference in metabolic pathways leading to unique metabolites.
    Li W; Zhang D; Wang L; Zhang H; Cheng PT; Zhang D; Everett DW; Humphreys WG
    Drug Metab Dispos; 2006 May; 34(5):807-20. PubMed ID: 16467134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fate of a thiazolidinedione antidiabetic agent in rat and dog.
    Bolton GC; Keogh JP; East PD; Hollis FJ; Shore AD
    Xenobiotica; 1996 Jun; 26(6):627-36. PubMed ID: 8810033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose proportionality studies of novel thiazolidinedione derivatives as potent antidiabetic agents in mice.
    Heitzmann T; Neidlein R; Freund P; Reiff K; Strein K
    Arzneimittelforschung; 1995 Dec; 45(12):1284-8. PubMed ID: 8595085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.